MIP-1alpha, rat recombinant protein
Small inducible cytokine A3, CCL3, Macrophage inflammatory protein 1-α, MIP-1-α, Tonsillar lymphocyt
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P50229 |
---|---|
Calculated MW | 7.8 kDa |
Gene ID | 25542 |
---|---|
Gene Symbol | CCL3 |
Other Names | Small inducible cytokine A3, CCL3, Macrophage inflammatory protein 1-α, MIP-1-α, Tonsillar lymphocyte LD78 α protein, G0/G1 switch regulatory protein 19-1, G0S19-1 protein, SIS-β, PAT 464, 1, chemokine (C-C motif) ligand 3, MIP1A, SCYA3, G0S19-1, LD78α, TY-5, SIS-α, Heparin-binding chemotaxis protein, L2G25B, |
Gene Source | Rat |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | HPLC; ≥95% |
Recombinant | Yes |
Results | 50-100 ng/ml |
Target/Specificity | MIP-1 alpha |
Application Notes | Reconstitute in H₂O to a concentration of 0.1-1 mg/ml. This solution can then be diluted into other aqueous buffers or stored at 4°C for 1 week or –20°C for future use. |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Rat macrophage inflammatory protein-1α (MIP-1α) is an 8.0 kDa protein containing 69 amino acid residues. It plays an important role in the inflammatory response of blood monocytes and tissue microphages.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.